Laboratory News and Research

RSS

GW researcher receives $3.6 million to study HIV-1 resistance to antibody treatments

The National Institutes of Health has awarded $3.6 million to Rebecca Lynch, PhD, assistant professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, to investigate HIV-1 resistance to antibody treatments.

16 Jul 2020

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.

16 Jul 2020

Lung cancer study highlights important factors for treating genomically complicated cancers

A pioneering lung cancer study, led by the University of Birmingham's Cancer Research UK Clinical Trials Unit, has highlighted important factors that will need to be considered in the next wave of precision medicine studies particularly in treating genomically complicated cancers.

16 Jul 2020

Study identifies factors associated with death in critically ill COVID-19 patients

More than 3 million people in the United States have been infected with COVID-19 and more than 130,000 have died. More people have died of COVID-19 in the U.S. than in any other country, but few studies offer national data on the factors that may contribute to outcomes for critically ill patients.

15 Jul 2020

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Given the disproportionate impact that COVID-19 has on older adults in terms of death and lasting disability, and the impact of common aging-related comorbidities like diabetes and cardiovascular disease, Buck Institute professor and practicing geriatrician John Newman, MD, PhD, can make a compelling argument that those infected with the SARS-CoV2 virus are suffering from an aging-related disease, no matter how old they are when they get infected.

15 Jul 2020

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Metabolic syndrome increases the risk of severe disease from viral infection, according to a review of the literature performed by a team of researchers from St. Jude Graduate School of Biomedical Sciences and the University of Tennessee Health Science Center, both in Memphis.

15 Jul 2020

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Most patients hospitalized with COVID-19 (coronavirus) pneumonia experienced improvement after receiving a Food and Drug Administration-approved drug normally given for rheumatoid arthritis, according to an observational study at Cedars-Sinai.

15 Jul 2020

Individuals exposed to early life stress more likely to develop youth-onset depression

A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that individuals exposed to early life stress (ELS) were more likely to develop a major depressive disorder (MDD) in childhood or adolescence than individuals who had not been exposed to ELS.

15 Jul 2020

Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting

A Health Trends study from researchers at Quest Diagnostics and the University of Pittsburgh Medical Center provides new evidence that the HPV screening test is significantly less likely to detect cervical cancer and precancer than cotesting, a method which combines HPV and Pap testing using the same specimen.

15 Jul 2020

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

BATM, a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces the launch of three new diagnostic kits to significantly advance the diagnosis of COVID-19 and other respiratory illnesses.

15 Jul 2020

World's first technology aims to help diagnose, treat and manage people with cystic fibrosis

World-first research led by Monash University could hold the key to better monitoring and treatment of lung disease associated with cystic fibrosis (CF) – a condition thousands of people are diagnosed with each year.

15 Jul 2020

NanoSurface Biomedical is now Curi Bio

NanoSurface Biomedical, a leading developer of human stem cell-based biotechnology products, today announced a comprehensive rebrand, including a change of the company’s name to Curi Bio.

From Curi Bio 15 Jul 2020

Proportion of healthcare-associated infections is higher than believed

One in four inpatients with influenza in a given season showed signs of having become infected during care. This is clear from a University of Gothenburg thesis about the spread of influenza in hospitals and how this problem can be remedied.

15 Jul 2020

Biological anti-tumor mechanism can provide long-term immune response against tumors

Blocking a newly identified "immune memory checkpoint" in immune cells could improve immunotherapy and help prevent cancers from recurring, according to new findings in mice and human samples by researchers at the UPMC Hillman Cancer Center and the University of Pittsburgh School of Medicine.

15 Jul 2020

Antibodies to SARS-CoV-2 disappear within three months

The question is, does this infection confer lasting immunity? A new study published in the journal Clinical Microbiology and Infection in July 2020 appears to show that it does not, with antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disappearing within three months of infection.

15 Jul 2020

Study shows why humans don’t see eye to eye on debatable matters

We humans may not always see eye to eye on politics, religion, sports, and other matters of debate. But at least we can agree on the location and size of objects in our physical surroundings.

15 Jul 2020

SwRI expands its services to include mask testing in response to COVID-19 pandemic

The Particle Science and Technology Laboratory at Southwest Research Institute has expanded its services to include mask testing in response to the COVID-19 pandemic.

15 Jul 2020

B-Ferst makes signs of progress despite the COVID-19 pandemic

One year has passed since B-Ferst kicked off in Madrid, in May 2019. As we all know, 2020 has probably been the most struggling year of the recent past.

15 Jul 2020

Nix gene can help develop future mosquito control techniques

Virginia Tech researchers have proven that a single gene can convert female Aedes aegypti mosquitoes into fertile male mosquitoes and identified a gene needed for male mosquito flight.

15 Jul 2020

Ashion's GEM ExTra assay receives Medicare coverage

Ashion Analytics LLC announced today that Palmetto GBA, a Medicare administrative contractor for the Molecular Diagnostic Services Program (MolDX), has awarded coverage to its proprietary cancer profiling test, GEM ExTra®, one of the nation's most comprehensive genomic cancer analysis tests.

15 Jul 2020

Laboratory News and Research

GW researcher receives $3.6 million to study HIV-1 resistance to antibody treatments

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Lung cancer study highlights important factors for treating genomically complicated cancers

Study identifies factors associated with death in critically ill COVID-19 patients

Buck researchers investigate ketone bodies as possible therapeutic against COVID-19

Obesity and metabolic syndrome increase risk for severe influenza, COVID-19

Anti-inflammatory medication helps fight dangerous immune response in COVID-19 patients

Individuals exposed to early life stress more likely to develop youth-onset depression

Quest Diagnostics Health Trends study: HPV screening less likely to detect cervical cancer than cotesting

BATM introduces three new diagnostic kits for COVID-19 and other respiratory illness

World's first technology aims to help diagnose, treat and manage people with cystic fibrosis

NanoSurface Biomedical is now Curi Bio

Proportion of healthcare-associated infections is higher than believed

Biological anti-tumor mechanism can provide long-term immune response against tumors

Antibodies to SARS-CoV-2 disappear within three months

Study shows why humans don’t see eye to eye on debatable matters

SwRI expands its services to include mask testing in response to COVID-19 pandemic

B-Ferst makes signs of progress despite the COVID-19 pandemic

Nix gene can help develop future mosquito control techniques

Ashion's GEM ExTra assay receives Medicare coverage

A guide to density measurement excellence eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo